Dr. Lal Pathlabs Limited Declares Second Interim Dividend for the Financial Year 2020-21, Payable on or before February 27, 2021
January 29, 2021 at 05:35 am
Share
The Board of Directors of Dr. Lal PathLabs Limited declared second interim dividend of INR 6 per equity share (60% on a face value of INR 10 per share) for the financial year 2020-21. The board has fixed February 10, 2021 as the record date for the purpose of payment of interim dividend. The interim dividend will be paid by the company on or before February 27, 2021.
Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services in India. The Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its tests include Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, CBC Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Liver Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and Vitamin D Test. The Company has approximately 280 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore and Mumbai), 5,762 patient service centers (PSCs) and 11,619 pick-up points (PUPs). Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
DR. LAL PATHLABS LIMITED 
